David Rishikof is an expert in the field of Pulmonology. He received awards:"Meaningful Use Stage 1 Certification". David Rishikof has written publications. He has 19 publications published with PubMed. The lastest publication is: 'The effect of prostaglandin E2 on cystine uptake and glutathione synthesis by human lung fibroblasts.' David C. Rishikof, MD accepts all Medicare patients.
NPI NUMBER | 1750360657 | |
NPPES Provider LastName | RISHIKOF | |
NPPES Provider FirstName | DAVID | |
NPPES Provider ZIPCode | 017026358 | |
NPPES Provider State | MA | |
Specialty Description | Pulmonary Disease | |
Total Claim Count | 506.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1750360657 |
Last Name Of The Provider | RISHIKOF |
First Name Of The Provider | DAVID |
View All |
![]() |
Dr. Richard G. Masson, MD
![]() |
![]() |
Dr. William H. Goodman, MD
![]() |
![]() |
Dr. Kedar S. Deshpande, MD
![]() |
![]() |
Dr. Jason M. Konter, MD
![]() |
![]() |
Dr. Sew-Leong Kwa, MD
![]() |